Pharmaceutical marketers were surprised to learn how extensively FDA
used social media and Web 2.0 in the new year. The recall of 3,400
contaminated peanut products in 2009 was described at an eMarketing
conference in Princeton, NJ. Pharma marketers heard that blogs, social
media, YouTube and Twitter were new tactics embraced by the regulatory
agency, at least in its communication with the public on an important
food safety issue. FDA, along with CDC and HHS, was pulled further into
social networking by growing public concern over the rapid growth and
diversity of the peanut-product recall list.
In the future, will
the FDA also be pulled into social media by a major Rx drug recall? What can the drug industry learn from the FDA's use of
social media and will FDA's example help guide the industry toward best
practices in this area?
This article describes FDA's social
networking initiatives in context of the above questions.
Topic headings include:
Read this article now. It's FREE...
- A Coordinated Campaign
- FDA and Twitter
- Improved Search Capability
- FDA's Social Media Peanut Recall Resources for Consumers
- FDA YouTube Peanut Recall Videos
- What's the Takeaway for Pharma?
- FDA Widgets: How About One for Adverse Event Reporting?
- Demise of the One-Click Rule?
- FDA and YouTube: Do as We Say, Not as We Do
- DDMAC Gets Bully Pulpit Again, But Strikes Out
Download PDF file